Sign in

NCT06886009Withdrawn

Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

A Regulatory Requirement Non-interventional Study to Monitor the Safety and Effectiveness of Spesolimab in Korean Patients With Flares With Generalized Pustular Psoriasis

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

The primary and secondary objectives are to respectively monitor the safety and effectiveness of Spesolimab IV in Korean patients with flares with generalized pustular psoriasis (GPP) in a routine medical practice.

Status (registry)
Withdrawn
Study type
Observational
Enrollment
0 (actual)
First submitted
19 Mar 2025
Start date
31 Mar 2026
Primary completion date
8 Jun 2029
Lead sponsor
Boehringer Ingelheim
Diseases
Psoriasis
NCT number
NCT06886009

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with Severe or life-threatening hypersensitivity to Spesolimab or to any of the excipients
  • Patients with clinically important active infections (e.g. active tuberculosis)

Who the study is looking for

  • Patients starting Spesolimab IV for the first time in accordance with the approved label in Korea (complete enumeration for the first 2 years after product launch)
  • Patients with generalized pustular psoriasis (GPP) flare
  • Age \>/=19 years at enrolment
  • Patients who have signed the data release consent form

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Pusan National University Yangsan Hospital
Coordinator of this site? Confirm its status
BusanSouth KoreaUnknown status
Asan Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Ajou University Hospital
Coordinator of this site? Confirm its status
SuwonSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.